Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

75.0%

3 terminated/withdrawn out of 4 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Early Phase 1

1(25.0%)

Phase 1

1(25.0%)

Phase 4

1(25.0%)

Phase 2

1(25.0%)

4Total

Early Phase 1(1)

Phase 1(1)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT00720577Early Phase 1Completed

Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.

Role: collaborator

NCT00679055Phase 1Terminated

A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED)

Role: collaborator

NCT00504088Phase 4Terminated

Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia

Role: lead

NCT00516308Phase 2Terminated

A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial Disease

Role: lead

All 4 trials loaded